首页>投融资
Amplexd Therapeutics
未透露
Amplexd Therapeutics正在开发两种低成本、新颖、非侵入性的疗法,用于治疗宫颈上皮内瘤变(宫颈癌前病变)。第一种是用于低级别CIN的阴道内栓剂,第二种是用于高级别CIN的光动力疗法 (PDT) 系统,每种系统都旨在选择性地靶向肿瘤细胞。这些治疗方法旨在通过减少对侵入性手术的需求,使发达国家妇女的范式现代化,并为低收入和中等收入地区的妇女提供可能挽救生命的护理。
基本信息
-
公司全称Amplexd Therapeutics Inc
-
类型早期宫颈癌治疗药物研发商
-
产业领域医疗器械、治疗设备
-
公司人数15人以下
-
地址9841 Washingtonian Boulevard, Suite 200, Gaithersburg, MD
-
联系电话
-
邮箱info@amplexd.com
-
成立时间2022-01-01
投融资
-
2024-05-20未透露200万美元未透露
相关投融资企业
C轮
Francis Medical is a dynamic medical device company committed to developing urological cancer treatments that are tough on cancer yet gentle on patients.In September 2020, Coloplast announced that it has completed a USD 4m (DKK 25m) equity investment in Francis Medical
收并购
Gynesonics is a developer of transcervical, uterus-preserving, incision-free technologies for diagnostic and therapeutic applications (avoiding invasive surgical techniques of hysterectomy or myomectomy for symptomatic uterine fibroids). Products include the Sonata system which combines intrauterine ultrasound guidance with targeted radiofrequency ablation.In April 2023, the company closed a financing round of $25M
未公开
BetaGlue Therapeutics是一家临床分期肿瘤公司,该公司开发了一种先进的放疗平台,能够对不可切除的实体瘤和手术切缘进行局部靶向治疗,称为YntraDose。